BlackRock’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-225,287
| Closed | -$290K | – | 5053 |
|
|
2017
Q4 | $290K | Buy |
225,287
+908
| +0.4% | +$1.17K | ﹤0.01% | 4076 |
|
|
2017
Q3 | $476K | Sell |
224,379
-525
| -0.2% | -$1.11K | ﹤0.01% | 4001 |
|
|
2017
Q2 | $653K | Buy |
224,904
+6,111
| +3% | +$17.7K | ﹤0.01% | 3898 |
|
|
2017
Q1 | $752K | Buy |
+218,793
| New | +$752K | ﹤0.01% | 3821 |
|
|
2016
Q2 | – | Sell |
-397
| Closed | -$2K | – | 3890 |
|
|
2016
Q1 | $2K | Buy |
397
+143
| +56% | +$720 | ﹤0.01% | 3445 |
|
|
2015
Q4 | $4K | Hold |
254
| – | – | ﹤0.01% | 3211 |
|
|
2015
Q3 | $5K | Hold |
254
| – | – | ﹤0.01% | 3042 |
|
|
2015
Q2 | $13K | Sell |
254
-21
| -8% | -$1.08K | ﹤0.01% | 2611 |
|
|
2015
Q1 | $22K | Hold |
275
| – | – | ﹤0.01% | 2301 |
|
|
2014
Q4 | $17K | Hold |
275
| – | – | ﹤0.01% | 2440 |
|
|
2014
Q3 | $12K | Hold |
275
| – | – | ﹤0.01% | 2605 |
|
|
2014
Q2 | $17K | Sell |
275
-2
| -0.7% | -$124 | ﹤0.01% | 2450 |
|
|
2014
Q1 | $18K | Buy |
277
+23
| +9% | +$1.5K | ﹤0.01% | 2406 |
|
|
2013
Q4 | $14K | Hold |
254
| – | – | ﹤0.01% | 2519 |
|
|
2013
Q3 | $16K | Hold |
254
| – | – | ﹤0.01% | 2380 |
|
|
2013
Q2 | $15K | Buy |
+254
| New | +$15K | ﹤0.01% | 2453 |
|